Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Design Therapeutics Inc
DSGNCurrent price
5.67 USD
+0.11 USD (+1.98%)
Last closed
5.6 USD
Company
www.designtx.com
ISIN
US25056L1035
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
316 791 680 USD
Yield for 12 month
+166.20 %
1Y
3Y
5Y
10Y
15Y
DSGN
Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California. Address: 6005 Hidden Valley Road, Carlsbad, CA, United States, 92011
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-537 000 USD
Last Year
-466 000 USD
Current Quarter
-151 000 USD
Last Quarter
-143 000 USD
Key Figures DSGN
1 year
3 years
5 years
10 years
EBITDA
-62 817 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.63 %
PEG Ratio
–
Return On Equity TTM
-18.11 %
Wall Street Target Price
7 USD
Revenue TTM
33 000 USD
Book Value
4.61 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-48 613 000 USD
Earnings per share
-0.9 USD
Diluted Eps TTM
-0.9 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DSGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DSGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation DSGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
11004.3527
Price Sales TTM
22642.0122
Enterprise Value EBITDA
-0.8361
Price Book MRQ
1.2126
Financials DSGN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DSGN
For 52 weeks
1.96 USD
6.91 USD
50 Day MA
5.07 USD
Shares Short Prior Month
2 587 779
200 Day MA
3.88 USD
Short Ratio
6.36
Shares Short
2 578 991
Short Percent
10.09 %
BeatStart